Prescription cough and cold medicines containing the opioid hydrocodone were more likely to cause serious side effects in children than those containing codeine, according to a new study. The research supports recent U.S. Food and Drug Administration (FDA) restrictions on prescription hydrocodone- and codeine-containing cough medicines for children and suggests that opioids in general should not be prescribed for coughs and colds in pediatric populations.

Kim Kardashian is making 2018 a year to remember. After the Keeping Up With the Kardashians star received the first-ever Influencer Award at the Council of Fashion Designers of America...

The spread of connected medical devices has left the health-care sector more exposed to cyberattacks.

It's strange the CMS proposal didn't come from the FDA.

A positive recommendation from an FDA advisory committee generates excitement among investors about this small biotech.

From Reagan’s press secretary laughing about the AIDs crisis to the activist group ACT UP shutting down the FDA, we look back at the early days of the epidemic.

The U.S. Food and Drug Administration has approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients.

The U.S. Food and Drug Administration has cleared the expanded use of the Vidas Brahms PCT Assay to help health care providers determine if antibiotic treatment should be started or stopped in...